心肌病的"帕杜瓦分类":结合了病理生物学基础和形态功能重塑
Domenico Corrado1, Gaetano Thiene1, Barbara Bauce1
1Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Italy.
International journal of cardiology
|September 21, 2024
概括
一个新的心肌病分类整合了遗传和临床特征,提出了三个类别:过度缩/限制性,扩张/低动力,痕/失常性. 这种方法有助于有针对性的患者管理和结果评估.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 分子生物学,遗传学和心磁共振 (CMR) 的进步改善了对心肌病的理解.
- 目前的诺斯图学框架需要修订,以纳入新的遗传和表型见解.
研究的目的:
- 为心肌病症提出一个新的定义和分类系统.
- 将病理生物学基础 (遗传学,分子病理学) 与临床表型 (形态功能特征) 结合起来.
主要方法:
- 关于心肌病的科学文献的综述.
- 基于病理生物学和临床表现的分类的开发.
- 三种疾病类别的建议:高变形/限制性 (H/RC),扩张/低动力 (D/HC) 和痕/失常性 (S/AC).
主要成果:
- 提出了针对心肌病的新分类系统.
- 每个类别由病因 (遗传/非遗传) 和结合的"解剖学"和"功能"特征来定义.
- 该分类促进了有针对性的临床管理和结果评估.
结论:
- 拟议的分类增强了对心肌病的理解和管理.
- 准确的分类对于个性化患者护理和评估治疗疗效至关重要.
- 对疾病机制的进一步研究可能会导致疾病特异性的治疗疗法.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Pathophysiology of Cardiac Performance
601
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
601
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Pulmonary Hypertension: Classification and Pathogenesis
156
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
156


